Advocacy Actions
Comments to National Medical Products Administration (NMPA) on the Implementation Regulations of Drug Administration Law (Draft Revisions))
European Chamber submitted a 60-page long comment to the National Medical Products Administration (NMPA) on the Implementation Regulations of the Drug Administration Law of the People's Republic of China (Draft Revisions) on 9th June.
Comments to the National Health Commission (NHC) on the Workplan for Temporarily Importing Drugs of Urgent Clinical Needs
The European Chamber submitted comments to the National Health Commission (NHC) on the Workplan for Temporarily Importing Drugs of Urgent Clinical Needs on 28th April.
Read moreSent Comments to the National Medical Products Administration (NMPA) on the Inspection Essentials for Drug Marketing Authorisation Holders
European Chamber submitted comments to the National Medical Products Administration (NMPA) on the Inspection Essentials for Drug Marketing Authorisation Holders on 28th April.
Read moreComments to MOST on the Implementing Rules of the Regulations for the Administration of Human Genetic Resources
On 21 April, the European Chamber submitted comments to the Ministry of Science and Technology on the Implementing Rules of the Regulations for the Administration of Human Genetic Resources.
Read moreOnline Meeting with China Society for Drug Regulation
Representatives of the European Chamber management and European Chamber Pharmaceutical Working Group held an online meeting with China Society for Drug Regulation on 30th March.
Read moreEuropean Chamber Attended CCPIT 2022 First Quarter Online Seminar with FIEs
On 25th March, the European Chamber attended the 2022 First Quarter Online Seminar on Business Environment for Foreign-invested Enterprises in China, organized by the research department of the China Council for the Promotion of International Trade (CCPIT).
Comments to Shanghai People's Congress on the Regulations of Shanghai Pudong New Area on Promoting Zhangjiang Biomedical Industry Innovation (Draft)
On 22nd December, European Chamber submitted a14-page long comments to Shanghai People's Congress on the Regulations of Shanghai Pudong New Area on Promoting Zhangjiang Biomedical Industry Innovation (Draft).
Read moreComments to National Health Commission (NHC) on the Administrative Measures of the National Essential Drugs List
On 14th December, European Chamber Pharmaceutical Working Group submitted comments to National Health Commission (NHC) on the Administrative Measures of the National Essential Drugs List.
Read moreMeeting with Mr. Ramunas Freigofas, First Counsellor for Health and Food Safety of EU Delegation to China
European Chamber representatives from agriculture, EU affairs, food and beverage, cosmetics, healthcare equipment, pharmaceutical sectors, met with Mr. Ramunas Freigofas, First Counsellor for Health and Food Safety of EU Delegation to China to exchange work priorities of both sides and plan for further cooperation.
Read moreSubmission of Comments on Draft Measures on Security Assessment of the Cross-border Transfer of Data
At the end of October, the Cybersecurity Administration of China (CAC) published a invitation to public consultation on the Measures on Security Assessment of the Cross-border Transfer of Data (Draft for comments).
Read more